176 related articles for article (PubMed ID: 29260856)
21. Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 β-lactamase at a teaching hospital in Shanghai, China.
Li Y; Guo Q; Wang P; Zhu D; Ye X; Wu S; Wang M
J Microbiol Immunol Infect; 2015 Feb; 48(1):101-8. PubMed ID: 24863499
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
[TBL] [Abstract][Full Text] [Related]
23. Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like.
Fernández-Cuenca F; Smani Y; Gómez-Sánchez MC; Docobo-Pérez F; Caballero-Moyano FJ; Domínguez-Herrera J; Pascual A; Pachón J
Int J Antimicrob Agents; 2011 Dec; 38(6):548-9. PubMed ID: 21940150
[No Abstract] [Full Text] [Related]
24. The outer membrane porin OmpW of Acinetobacter baumannii is involved in iron uptake and colistin binding.
Catel-Ferreira M; Marti S; Guillon L; Jara L; Coadou G; Molle V; Bouffartigues E; Bou G; Shalk I; Jouenne T; Vila-Farrés X; Dé E
FEBS Lett; 2016 Jan; 590(2):224-31. PubMed ID: 26823169
[TBL] [Abstract][Full Text] [Related]
25. The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.
Wang-Lin SX; Olson R; Beanan JM; MacDonald U; Balthasar JP; Russo TA
Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28947651
[No Abstract] [Full Text] [Related]
26. In vivo protein interaction network analysis reveals porin-localized antibiotic inactivation in Acinetobacter baumannii strain AB5075.
Wu X; Chavez JD; Schweppe DK; Zheng C; Weisbrod CR; Eng JK; Murali A; Lee SA; Ramage E; Gallagher LA; Kulasekara HD; Edrozo ME; Kamischke CN; Brittnacher MJ; Miller SI; Singh PK; Manoil C; Bruce JE
Nat Commun; 2016 Nov; 7():13414. PubMed ID: 27834373
[TBL] [Abstract][Full Text] [Related]
27. [Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains].
Yıldırım MI; Tuğrul HM
Mikrobiyol Bul; 2011 Jul; 45(3):422-9. PubMed ID: 21935775
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
29. A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.
Wang C; Zhao G; Wang S; Chen Y; Gong Y; Chen S; Xu Y; Hu M; Wang X; Zeng H; Wang A; Liu D; Su Y; Cheng T; Chen F; Wang J
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158275
[TBL] [Abstract][Full Text] [Related]
30. Molecular and structural characterization of the HMP-AB gene encoding a pore-forming protein from a clinical isolate of Acinetobacter baumannii.
Gribun A; Nitzan Y; Pechatnikov I; Hershkovits G; Katcoff DJ
Curr Microbiol; 2003 Nov; 47(5):434-43. PubMed ID: 14669924
[TBL] [Abstract][Full Text] [Related]
31. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
[TBL] [Abstract][Full Text] [Related]
32. The Acinetobacter Outer Membrane Contains Multiple Specific Channels for Carbapenem β-Lactams as Revealed by Kinetic Characterization Analyses of Imipenem Permeation into Acinetobacter baylyi Cells.
Morán-Barrio J; Cameranesi MM; Relling V; Limansky AS; Brambilla L; Viale AM
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069648
[TBL] [Abstract][Full Text] [Related]
33. Structure-function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii.
Catel-Ferreira M; Coadou G; Molle V; Mugnier P; Nordmann P; Siroy A; Jouenne T; Dé E
J Antimicrob Chemother; 2011 Sep; 66(9):2053-6. PubMed ID: 21705362
[TBL] [Abstract][Full Text] [Related]
34. Molecular docking and simulation of the interaction of sulbactam with Acinetobacter baumannii BaeSR and AdeSR.
Ho KH; Su SC; Lee KR
Biochem Biophys Res Commun; 2021 Nov; 580():81-86. PubMed ID: 34627000
[TBL] [Abstract][Full Text] [Related]
35. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.
Vila J; Martí S; Sánchez-Céspedes J
J Antimicrob Chemother; 2007 Jun; 59(6):1210-5. PubMed ID: 17324960
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
Dinc G; Demiraslan H; Elmali F; Ahmed SS; Metan G; Alp E; Doganay M
Chemotherapy; 2013; 59(5):325-9. PubMed ID: 24525528
[TBL] [Abstract][Full Text] [Related]
37. Combination of BauA and OmpA elicit immunoprotection against Acinetobacter baumannii in a murine sepsis model.
Tamehri M; Rasooli I; Pishgahi M; Jahangiri A; Ramezanalizadeh F; Banisaeed Langroodi SR
Microb Pathog; 2022 Dec; 173(Pt A):105874. PubMed ID: 36356792
[TBL] [Abstract][Full Text] [Related]
38. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Turk Dagi H; Kus H; Arslan U; Tuncer I
Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
[TBL] [Abstract][Full Text] [Related]
39. Identification of an OprD homologue in Acinetobacter baumannii.
Dupont M; Pagès JM; Lafitte D; Siroy A; Bollet C
J Proteome Res; 2005; 4(6):2386-90. PubMed ID: 16335991
[TBL] [Abstract][Full Text] [Related]
40. Famotidine Enhances Rifampicin Activity against Acinetobacter baumannii by Affecting OmpA.
Zhang MN; Zhao XO; Cui Q; Zhu DM; Wisal MA; Yu HD; Kong LC; Ma HX
J Bacteriol; 2023 Aug; 205(8):e0018723. PubMed ID: 37439688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
